Business Wire

Sun European Partners, LLP: DD Group Acquires Leading European Dental Distribution Platform DPI

Share

Sun European Partners, LLP (“Sun European Partners” or “Sun European”), a leading private investment advisory firm focused on defensible businesses in growing markets with tangible performance improvement opportunities, today announces that its affiliated portfolio company DD Group has acquired 100% of the shares in Dental Promotion & Innovation SA (“DPI”) a leading dental distribution platform in continental Europe.

DPI is the largest dental distributor in Belgium, the third largest in France, and has a strong presence in Germany and the Netherlands. The transaction expands DD Group’s distribution coverage beyond the UK and Ireland into Western Europe and offers significant potential for synergies between the two businesses. DPI’s distribution capabilities will be added to DD Group’s current infrastructure, creating a pan-European leader in the distribution of dental consumables, equipment, laboratory services, aesthetics, and related services.

Value creation is expected to be driven through organic growth opportunities, underpinned by growing demand for dentistry and aesthetic treatments and realisation of synergies between the two businesses. Sun European will deploy its operational expertise to support the integration and identify areas for improved processes and efficiencies.

Alexander Wyndham, Principal, Sun European Partners LLP, said “the acquisition of DPI is a highly transformative deal for DD Group. For Sun European, our first objective following the acquisition of DD Group last year was to create a European leader, and we are delighted to see the business expanding. DPI has very strong growth prospects and the acquisition will act as a springboard for further bolt-ons across continental Europe.”

CEO of DD Group, Sam Tyrer, said “this acquisition represents a transformational moment in our company’s long history, being our first foray into continental Europe, enabling us to continue the company’s expansion and consolidate our presence in the European dental market. DD Group is acquiring a high-quality business with an outstanding team who have made an important contribution to the success and consistent growth of DPI over the past 20 years.”

David Vancutsem, DPI’s Founder and CEO, added “As founder and CEO of DPI, I am delighted to have found a like-minded and supportive partner in DD Group. We share the same ambitious aspirations for the business, and I look forward to working alongside DD Group as we aim to create Europe’s leading dental distribution platform.”

- Ends -

About Sun European Partners, LLP

Sun European Partners, LLP is a leading private investment advisory firm, focused on partnering with outstanding management teams to accelerate value creation. Since 1995, affiliates of Sun European have invested in more than 500 companies worldwide with revenues in excess of €40 billion across a broad range of industries and transaction structures. The Firm has built a reputation as a trusted partner, recognised for its operational experience. Sun European focuses on defensible businesses in growing markets with tangible performance improvement opportunities in the Business Services, Consumer, Healthcare, Industrial, and Technology sectors. Sun European Partners has offices in London and affiliates with offices in Boca Raton, Los Angeles, and New York.

For more information, please visit www.suneuropeanpartners.com.

About DD Group

Founded over 50 years ago, DD (formerly branded Dental Directory) is the only integrated distribution and demand creation platform for products and services for both dental and medical aesthetics customers. Through a unique ‘one-stop shop’, customers have access to over 30,000 dental and medical aesthetics products, prescription medicines, equipment and technology alongside dental engineering and compliance services. DD Group is an affiliated portfolio company of Sun European Partners, LLP.

About DPI

Founded in 2004, DPI is a leading European distributor of dental consumables and has its own laboratory to produce crowns and bridges. Headquartered in Anderlecht, the group services nearly 30,000 customers across Belgium, France, Germany, Netherlands and Luxembourg, with a strong focus on long term relationships with leading dental product manufacturers and complimented by excellent customer service and strong product availability.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media contacts:

S un European Partners, LLP.
Camarco (United Kingdom)
Jen Renwick / Julia Tilley
+44 7928 471 013 / +44 7586 722 849
SunEuropeanPartners@Camarco.co.uk

Sun European Partners, LLP.
Bellier Financial (The Netherlands)
Jakob Geerts
Singel 266
1016 AC Amsterdam
The Netherlands
jakob.geerts@bellierfinancial.com
T: +31 20 419 0901
F: +31 6 8342 9715

DD Group
media@ddgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)14.5.2025 09:14:00 EEST | Press release

GSK plc (LSE/NYSE: GSK) and Boston Pharmaceuticals, a leading clinical stage biopharmaceutical company developing highly targeted therapies for patients with serious liver diseases, today announced that they have entered into an agreement under which GSK will acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa. Efimosfermin is a phase III-ready, potential best-in-class, investigational specialty medicine to treat and prevent progression of steatotic liver disease (SLD). Under the agreement, GSK will pay $1.2 billion upfront, with potential for additional success-based milestone payments totalling $800 million. Efimosfermin is a novel, once-monthly fibroblast growth factor 21 (FGF21) analog therapeutic in clinical development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), including cirrhosis, and future development in alcohol-related liver disease (ALD), both forms of SLD. Given efimosfermin’s direct antifibrotic mechanism of action and GSK’s dat

Reply Presents “App to the Future”: A New AI-Scape Room Experience Powered by Microsoft AI and Low-Code Solutions14.5.2025 09:05:00 EEST | Press release

Reply, a global systems integrator and technology consulting firm, introduces “App to the Future” an immersive “AI-Scape Room” an immersive escape room experience powered by Microsoft Copilot, Azure AI, and Power Platform, designed to explore the full potential of AI and low-code tools in a unique and engaging way. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513072546/en/ The experience builds on Reply’s AI-Scape Room focused on Microsoft 365 Copilot, offering enhanced challenges and deeper integration of advanced AI tools to help participants better understand how these technologies can drive business transformation. Developed by WM Reply and Valorem Reply, the Reply companies specialised in digital workplace transformation and AI solutions, “App to the Future” invites participants to engage in an interactive experience where they tackle AI-powered challenges using Microsoft’s suite of tools - including Copilot, Azure

Svante Launches World's First Commercial Gigafactory for Carbon Capture & Removal Filters13.5.2025 23:50:00 EEST | Press release

Svante Technologies Inc. (Svante), a global leader in carbon capture and removal technologies, has officially completed the commissioning of its new Centre of Excellence for Carbon Capture and Removal – Redwood manufacturing Facility (Redwood) in Burnaby, British Columbia. This milestone marks the launch of the world's first gigafactory dedicated to producing commercial-scale carbon capture and removal filters designed to trap CO2 directly from industrial emissions and the atmosphere, and with the mindset of high-volume automation and product standardization to lower the manufacturing cost. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513713072/en/ Claude Letourneau, President & CEO, Svante Group opens the Svante Grand Opening 2025 event, "GO25" with a speech about how to move the carbon management industry forward. This two-day event celebrates the commissioning of Svante's gigafactory in Vancouver, BC, Canada, which w

Svante and SAMSUNG E&A Sign Joint Development Agreement to Offer Digitally Enabled Skid-Mounted Modular Carbon Capture Plants13.5.2025 23:46:00 EEST | Press release

Svante Technologies Inc. (Svante) and SAMSUNG E&A announced today that they have signed a joint development agreement to jointly develop a set of standardized skid-mounted modular carbon capture plants based on Svante’s novel VeloxoTherm solid sorbent-based carbon capture filter technology, leveraging SAMSUNG E&A’s advanced digital solutions and modularization capabilities. The agreement was signed during Svante’s Grand Opening Event, which marked the commissioning of its new commercial filter manufacturing facility in Vancouver, Canada. This is the world’s first gigafactory for Svante’s filter technology, capable of producing enough filters to capture 10 million tonnes of CO2 annually. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513282760/en/ Leaders of SAMSUNG E&A and Svante sign a joint development agreement at a private signing ceremony during Svante's Grand Opening Event in Burnaby, BC, Canada. The companies have

AWS and HUMAIN Announce Groundbreaking AI Zone to Accelerate AI Adoption in Saudi Arabia and Globally13.5.2025 19:09:00 EEST | Press release

Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), and HUMAIN, Saudi Arabia’s newly created company responsible for driving AI innovation across the Kingdom and globally, today announced plans to invest $5 billion-plus in a strategic partnership to build a groundbreaking “AI Zone” in the Kingdom. This first-of-a-kind AI Zone will bring together multiple innovative capabilities, including dedicated AWS AI infrastructure and servers with world-class semiconductors, UltraCluster networks for faster AI training and inference, AWS services like SageMaker and Bedrock, and AI application services such as Amazon Q to advance Saudi Arabia’s mission to be a world leader in AI. AWS previously announced and is currently building an AWS infrastructure region in Saudi Arabia that will become available in 2026. Amazon is investing US$5.3 billion (approx. 19.88 billion Saudi riyal) in Saudi Arabia to develop this new region for AWS. The new AI Zone announced today is an addit

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye